Charles E. and Susan T. Harris Professor, MIT Sloan School of Management; Director, MIT Laboratory for Financial Engineering
Estimating Probabilities of Success of Vaccine and Other Anti-Infective Therapeutic Development Programs
New estimates offer guidance to biopharma investors and policymakers seeking to identify areas most likely to be underserved by private sector engagement and in need of public sector support.
Teaching: No Longer Just For The Classroom
In addition to lecturing for the students at MIT, technology is taking Andrew’s classes off-campus and across the globe.
Bayesian Adaptive Clinical Trials for Anti-Infective Therapeutics During Epidemic Outbreaks
New research illustrate the importance of adapting the clinical trial design and the regulatory approval process to the specific parameters and stage of the epidemic.
Advising the Next Generation
See Andrew’s students, current and former, who have and will go on to be leaders in their respective industries.
Spectral Factor Models
Recent research shows that traditional factor models restriction of spectral betas can hide horizon-specific pricing effects which spectral factor models are designed to reveal.
Will a Covid-19 Vaccine Change the Future of Medical Research?
Andrew recently joined Freakonomics Radio to discuss Covid-19 may finally change how diseases are cured.